Viewing Study NCT02268604


Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2025-12-25 @ 6:58 PM
Study NCT ID: NCT02268604
Status: TERMINATED
Last Update Posted: 2014-10-20
First Post: 2014-08-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Different Oral Doses of BIIB 722 CL Tablets in Healthy Volunteers
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module